Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

101.40
-0.6800-0.67%
Volume:824.77K
Turnover:83.78M
Market Cap:25.47B
PE:-13.05
High:103.00
Open:102.01
Low:100.84
Close:102.08
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.46
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.23
PE(LYR):-18.37

Loading ...

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live
·
May 28

Pfizer, BioNTech Prepared to Supply 2026-2027 Covid Vaccine Formula per FDA Recommendation and Upon Approval: Briefing Docs

THOMSON REUTERS
·
May 28

BioNTech Raised to Buy From Neutral by UBS

Dow Jones
·
May 28

BioNTech's Cancer Pipeline Seen Strengthening Ahead of Key Trial Results, UBS Says

MT Newswires Live
·
May 28

This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative. -- Barrons.com

Dow Jones
·
May 27

UBS Upgrades BioNTech to Buy From Neutral, Adjusts Price Target to $135 From $117

MT Newswires Live
·
May 27

BioNTech upgraded to Buy from Neutral at UBS

TIPRANKS
·
May 27

GeoVax Labs discontinues development of COVID-19 vaccine candidate

TIPRANKS
·
May 27

Roth Capital ‘strongly’ agrees with GeoVax ending COVID-19 development

TIPRANKS
·
May 27

Wells Fargo Keeps Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
May 25

Fact Check: Viral Video of Hantavirus Patient Treatment Is Actually from Covid-19

Tempo
·
May 24

BioNTech’s ctDNA Colorectal Cancer Study Signals Next Steps in Its Oncology Strategy

TIPRANKS
·
May 23

Novavax Updates Pediatric COVID-19 Vaccine Trial: What Investors Should Watch

TIPRANKS
·
May 23

BioNTech Initiated at Market Perform by Bernstein

Dow Jones
·
May 22

BioNTech Highlights Late-Stage Oncology Pipeline and New Data Ahead of 2026 ASCO Meeting

TIPRANKS
·
May 22

Bernstein Initiates Coverage on BioNTech With Market Perform Rating

MT Newswires Live
·
May 22

BioNTech reports Phase 2/3 ROSETTA Lung-02 pumitamig data in first-line NSCLC

Reuters
·
May 22

Bernstein starts BioNTech at Market Perform, sees high registration risk

TIPRANKS
·
May 22

Analysts Conflicted on These Healthcare Names: InMode (INMD), Achieve Life Sciences (ACHV) and BioNTech SE (BNTX)

TIPRANKS
·
May 21

J.P. Morgan Keeps Their Hold Rating on BioNTech SE (BNTX)

TIPRANKS
·
May 20